On November 21, 2013, Amarin (Nasdaq: AMRN) received notification from the dispute resolution group of the Office of New Drugs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE